Hook & thesis
Berkshire Hathaway has moved from hoarding cash to putting it to work. Under Greg Abel, management deployed roughly $35 billion in Q2 2026 across acquisitions, strategic stakes and buybacks, yet the company still sits on roughly $360 billion of available cash. That pivot matters: a giant insurer and industrial conglomerate with a market cap of about $1.07 trillion is now deploying capital in a way that should lift intrinsic value over the next few quarters.
My thesis: upgrade Berkshire to a tactical buy. The stock is attractively valued relative to its earnings power (reported P/E near 12.7, price-to-book ~1.45), management is executing a clear capital-return and acquisition plan, and buyback activity plus meaningful strategic investments (Alphabet stake, Taylor Morrison acquisition) create positive earnings and optionality. The trade is a mid-term buy with a clear entry at $752,830, a stop at $700,000 and a realistic target at roughly the stock's 52-week high of $806,102.81.
Business primer - why the market should care
Berkshire Hathaway is a diversified holding company that operates insurance (including GEICO and the reinsurance group), Burlington Northern Santa Fe (BNSF) rail, Berkshire Hathaway Energy, manufacturing, distribution and retailing. The company has strong cash generation: free cash flow in recent reporting was $23.872 billion, and return-on-equity sits near 10%.
Why this matters now: insurance float and operating cashflows fund acquisitions and buybacks without needing to lever the balance sheet. Management has historically been the primary driver of shareholder returns; the recent move from conservative cash hoarding to active deployment signals a valuation catalyst. The market cap at about $1.074 trillion and a P/E in the low-to-mid teens gives room for multiple expansion if buybacks continue and acquired businesses compound value.
Evidence - the numbers that back the upgrade
- Q2 2026 deployment: management used ~ $35 billion in cash for equity stakes, a $6.8 billion acquisition (Taylor Morrison), and roughly $4.2 - $4.5 billion in buybacks.
- Cash reserves: roughly $360 billion remain on the balance sheet after deployments, offering optionality for further buybacks or larger acquisitions.
- Valuation: market cap is approximately $1.074 trillion. Key multiples: P/E ~12.7, price-to-book ~1.45 and enterprise value about $1.149 trillion.
- Cash generation: free cash flow reported at $23.872 billion gives a steady funding base for operations and capital allocation.
Technical context
Technicals are mixed. The 50-day simple moving average sits around $748,870 and the current price of $752,830 is modestly above that level, which provides a base. Shorter-term averages are higher - the 10-day is near $772,130 - and momentum indicators show a muted reading (RSI ~46) with MACD in bearish momentum. Volume is light relative to shares outstanding; the two-week average volume is about 160 shares (this is reflecting the class A trading conventions), and short-interest days-to-cover remains low. In short: fundamentals support a buy, but expect some chop as the market digests large capital deployment news.
Valuation framing
At a P/E roughly 12.7 and price-to-book ~1.45, Berkshire is trading at a discount to what you would expect for a conglomerate with higher-than-average returns on equity and substantial dry powder. Enterprise value to sales is around 3.37 and EV/EBITDA ~27.1. These numbers suggest a conservative market pricing relative to cash and earning power; the case for multiple expansion rests on continued disciplined deployments and steady buyback execution.
Compare this to the historical narrative of Berkshire: the company has historically given shareholders above-market returns through accretive investments and buybacks. With management accelerating capital returns, there is a straightforward path to boost EPS and intrinsic value over the medium term.
Catalysts (what to watch)
- Ongoing buybacks: management bought roughly $4.2 - $4.5 billion in Q2 2026. Continued buybacks would be an earnings-per-share tailwind and likely support multiple expansion.
- Further acquisitions: management already closed the $6.8 billion Taylor Morrison deal - similar-sized bolt-ons or larger strategic purchases could reshape growth prospects.
- Portfolio deployments into high-growth areas: a $10 billion placement into Alphabet and increased positions in Japanese trading houses point to selective equity investments that could appreciate rapidly.
- Quarterly results and any formal commentary on capital allocation plans - especially intentions around the remaining ~$360 billion cash balance - will drive sentiment.
- Macro: an improving economy would help BNSF volumes and housing-related businesses (Taylor Morrison exposure), while deterioration could pressure those segments.
Trade plan - actionable and specific
Horizon: mid term (45 trading days). I expect the primary price action to unfold as markets digest buyback cadence and the first set of Q3 results and 13F disclosures under Abel's stewardship.
| Action | Price | Rationale |
|---|---|---|
| Entry | $752,830.00 | Near current trading level and above the 50-day moving average; allows participation in buyback/m&a news flow. |
| Stop loss | $700,000.00 | Below the 52-week low ($698,000), limits downside if the market reprices conglomerates or if insurance losses spike. |
| Target | $806,102.81 | Near the 52-week high; realistic mid-term upside as buybacks and realized gains drive sentiment and multiples. |
Position sizing: treat this as a core-rotation trade. Because of concentrated exposure to insurance, rail and energy, limit any single-trade size to an amount consistent with your portfolio volatility tolerance (I recommend no more than 3-5% of total portfolio capital for most retail investors on this mid-term trade).
Risks and counterarguments
Investors should be explicit about the primary risks that could derail this trade:
- Execution risk on acquisitions and capital deployment: Large deals can take time to generate value. If acquisitions prove overpaid or integration is poor, EPS could suffer despite the cash deployed.
- Insurance loss shocks: A major catastrophe year could force underwriting losses and draw on capital, pressuring cash flow and share price.
- Rail and industrial cyclicality: BNSF volumes are exposed to economic cycles. A macro slowdown or sustained decline in freight demand would hurt revenue and profitability.
- Multiple compression risk: If markets rotate away from financials/conglomerates or if interest rates move unexpectedly, Berkshire’s P/E and EV/EBITDA could compress further.
- Concentration and liquidity: Class A shares trade lightly relative to large-cap indices; heavy selling by large holders or index reweighting could create temporary dislocations.
Counterargument
One could argue this is not the right time to add exposure because management is deploying cash aggressively after an extended period of caution. Aggressive buying increases the risk of overpaying into peak prices (especially for large equity stakes) or making acquisitions at cyclical highs. If buybacks are the primary tool, they only help shareholders if the repurchases are at prices below intrinsic value - and the market may not agree on where that line is. In short: returns are not guaranteed simply because cash is being deployed; the quality of those deployments matters.
What would change my mind
I would reconsider this buy if any of the following occur: management discloses materially larger-than-expected underwriting losses; cash reserves fall sharply without transparent, accretive uses; or the company signals a pause/stop to buybacks. Conversely, sustained and material buybacks combined with accretive acquisitions that are clearly value-creating would make me more bullish and prompt raising the target.
Conclusion - clear stance
Upgrade to a tactical buy on BRK.A for the mid term (45 trading days). The combination of an attractive P/E near 12.7, sizable remaining cash of roughly $360 billion, active buybacks and strategic acquisitions provides a reasonable path for share-price appreciation toward the 52-week high near $806k. Treat the trade as a disciplined, sized position, use the $700,000 stop to protect capital, and monitor buyback cadence and acquisition execution closely. If management continues to deploy cash prudently, the upside should comfortably justify this calculated risk.
Trade plan summary: Entry $752,830.00 | Stop $700,000.00 | Target $806,102.81 | Horizon: mid term (45 trading days)
Note: This is a trade idea with explicit entry and exit levels. Adjust position size to your risk tolerance and account for the concentrated nature of Class A shares when sizing.